18.2
CONSOLIDATED REVENUES
at €18.2m, +19% compared to 2023 (€15.3m). Revenue growth from business lines was +21% (+23% on a like-for-like basis).
1.0
Adjusted EBITDA
at 1.0 million euros (-0.3 million euros in FY2023), accelerating in the second half of the year to 1.1 million euros. The revenue margin significantly improved to 6% in 2024 (-2% in FY2023), thanks to the continued focus on higher value-added products and solutions
0.7
CASH AVAILABLE
at +€0.7 million as of December 31, 2024 (+€2.4 million in FY2023). In line with the plan, the company invested €2.7 million in R&D for the development of its products, consistent with the previous year. It is worth noting that, despite maintaining a high level of investments, the cash absorption in 2024 recorded a reduction of over 40% compared to the previous year